Militia Capital Management LLC Takes Position in Acadia Healthcare Company, Inc. $ACHC

Militia Capital Management LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 121,500 shares of the company’s stock, valued at approximately $2,842,000.

A number of other institutional investors have also bought and sold shares of ACHC. EverSource Wealth Advisors LLC boosted its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd purchased a new stake in Acadia Healthcare during the 4th quarter valued at $52,000. GAMMA Investing LLC lifted its position in Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after buying an additional 2,698 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after buying an additional 5,203 shares during the period.

Analyst Ratings Changes

A number of research firms recently commented on ACHC. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a research note on Monday, May 4th. UBS Group raised their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Guggenheim boosted their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. KeyCorp upped their target price on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Finally, Royal Bank Of Canada raised their price target on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $34.78 on Thursday. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The company has a market capitalization of $3.20 billion, a PE ratio of -2.84, a P/E/G ratio of 11.88 and a beta of 0.64. The company has a 50 day moving average price of $27.32 and a 200-day moving average price of $22.96. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.Acadia Healthcare’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the business posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.